Latest News
- November 18, 2025ANDA application for Bimatoprost ophthalmic solution received Marketing Authorization from the USFDA!
- November 12, 2025ANDA application for Risperidone extended-release injectable suspension has received Marketing Authorization from the USFDA!
- October 30, 2025Accelerating Clinical Research!
- September 12, 2025Join CBCC at CPHI Frankfurt 2025
- August 08, 2025International Publication of Phase II clinical Trial
May 26, 2022
We are attending the 2022 ASCO Annual Meeting
CBCC Global Research will be at the 2022 ASCO Annual Meeting.
2022 ASCO Annual Meeting is a unique and unparalleled opportunity to connect with one of the largest, most diverse audiences in global cancer care.
Date: June 3 – 7, 2022
Location: Chicago, IL
For business appointments please email us at bd@cbcc.global
Submit RFP to CBCC Global Research for your clinical program(s):
https://lnkd.in/dGEP2wy3
